Market Research Logo

Europe Ovarian Cancer Market and Competitive Landscape – 2017

Europe Ovarian Cancer Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Ovarian Cancer Market and Competitive Landscape – 2017, provides comprehensive insights into Ovarian Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Ovarian Cancer market size and drug sales. This research also provides insights into Ovarian Cancer epidemiology and late stage pipeline.
The report is classified into nine sections – Ovarian Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Ovarian Cancer pipeline insights covering late stage clinical trials pipeline; Ovarian Cancer prevalence trends by countries; Ovarian Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Ovarian Cancer pipeline: Find out the drugs in clinical trials for Ovarian Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Ovarian Cancer epidemiology: Find out the prevalence of Ovarian Cancer by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Ovarian Cancer products: Identify key products marketed and prescribed for Ovarian Cancer by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Ovarian Cancer market size: Find out the market size for Ovarian Cancer drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Ovarian Cancer drug sales: Find out the sales of Ovarian Cancer drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Ovarian Cancer drugs sales forecast: Sales forecast for Ovarian Cancer drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Ovarian Cancer market share analysis: Find out the market shares of Ovarian Cancer drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Ovarian Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Ovarian Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Ovarian Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Ovarian Cancer: Disease Overview
1.1. Ovarian Cancer Symptoms
1.2. Ovarian Cancer Etiology
1.3. Ovarian Cancer Diagnosis
1.4. Ovarian Cancer Treatment Options
2. Ovarian Cancer Pipeline Insights
2.1. Ovarian Cancer Phase 3 Clinical Trials
2.2. Ovarian Cancer Phase 2 Clinical Trials
2.3. Ovarian Cancer Phase 1 Clinical Trials
3. Ovarian Cancer Epidemiology Analysis
4. Germany Ovarian Cancer Market Insights
4.1. Marketed Products for Ovarian Cancer in Germany
4.2. Germany Ovarian Cancer Market Size & Forecast
4.3. Germany Ovarian Cancer Product Sales Forecast
4.4. Germany Ovarian Cancer Market Share Analysis
5. France Ovarian Cancer Market Insights
5.1. Marketed Products for Ovarian Cancer in France
5.2. France Ovarian Cancer Market Size & Forecast
5.3. France Ovarian Cancer Product Sales Forecast
5.4. France Ovarian Cancer Market Share Analysis
6. Italy Ovarian Cancer Market Insights
6.1. Marketed Products for Ovarian Cancer in Italy
6.2. Italy Ovarian Cancer Market Size & Forecast
6.3. Italy Ovarian Cancer Product Sales Forecast
6.4. Italy Ovarian Cancer Market Share Analysis
7. Spain Ovarian Cancer Market Insights
7.1. Marketed Products for Ovarian Cancer in Spain
7.2. Spain Ovarian Cancer Market Size & Forecast
7.3. Spain Ovarian Cancer Product Sales Forecast
7.4. Spain Ovarian Cancer Market Share Analysis
8. UK Ovarian Cancer Market Insights
8.1. Marketed Products for Ovarian Cancer in UK
8.2. UK Ovarian Cancer Market Size & Forecast
8.3. UK Ovarian Cancer Product Sales Forecast
8.4. UK Ovarian Cancer Market Share Analysis
9. Europe Ovarian Cancer Market Insights
9.1. Europe Ovarian Cancer Market Size & Forecast
9.2. Europe Ovarian Cancer Product Sales Forecast
9.3. Europe Ovarian Cancer Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Ovarian Cancer Phase 3 Clinical Trials, Global, 2017
Table 2: Ovarian Cancer Phase 2 Clinical Trials, Global, 2017
Table 3: Ovarian Cancer Phase 1 Clinical Trials, Global, 2017
Table 4: Ovarian Cancer Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Ovarian Cancer in Germany, 2017
Table 6: Germany Ovarian Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Ovarian Cancer Product Sales ($mn), 2012 - 2021
Table 8: Germany Ovarian Cancer Market Trends, 2012 - 2021
Table 9: Marketed Products for Ovarian Cancer in France, 2017
Table 10: France Ovarian Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Ovarian Cancer Product Sales ($mn), 2012 - 2021
Table 12: France Ovarian Cancer Market Trends, 2012 - 2021
Table 13: Marketed Products for Ovarian Cancer in Italy, 2017
Table 14: Italy Ovarian Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Ovarian Cancer Product Sales ($mn), 2012 - 2021
Table 16: Italy Ovarian Cancer Market Trends, 2012 - 2021
Table 17: Marketed Products for Ovarian Cancer in Spain, 2017
Table 18: Spain Ovarian Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Ovarian Cancer Product Sales ($mn), 2012 - 2021
Table 20: Spain Ovarian Cancer Market Trends, 2012 - 2021
Table 21: Marketed Products for Ovarian Cancer in UK, 2017
Table 22: UK Ovarian Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Ovarian Cancer Product Sales ($mn), 2012 - 2021
Table 24: UK Ovarian Cancer Market Trends, 2012 - 2021
Table 25: Europe Ovarian Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Ovarian Cancer Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Ovarian Cancer Pipeline by Phase (%), Global, 2017
Figure 2: Ovarian Cancer Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Ovarian Cancer Market Size ($mn), 2012 - 2021
Figure 4: Germany Ovarian Cancer Product Sales ($mn), 2012 - 2021
Figure 5: Germany Ovarian Cancer Market Share by Products (%), 2016
Figure 6: Germany Ovarian Cancer Market - Future Market Share (%), 2021
Figure 7: France Ovarian Cancer Market Size ($mn), 2012 - 2021
Figure 8: France Ovarian Cancer Product Sales ($mn), 2012 - 2021
Figure 9: France Ovarian Cancer Market Share by Products (%), 2016
Figure 10: France Ovarian Cancer Market - Future Market Share (%), 2021
Figure 11: Italy Ovarian Cancer Market Size ($mn), 2012 - 2021
Figure 12: Italy Ovarian Cancer Product Sales ($mn), 2012 - 2021
Figure 13: Italy Ovarian Cancer Market Share by Products (%), 2016
Figure 14: Italy Ovarian Cancer Market - Future Market Share (%), 2021
Figure 15: Spain Ovarian Cancer Market Size ($mn), 2012 - 2021
Figure 16: Spain Ovarian Cancer Product Sales ($mn), 2012 - 2021
Figure 17: Spain Ovarian Cancer Market Share by Products (%), 2016
Figure 18: Spain Ovarian Cancer Market - Future Market Share (%), 2021
Figure 19: UK Ovarian Cancer Market Size ($mn), 2012 - 2021
Figure 20: UK Ovarian Cancer Product Sales ($mn), 2012 - 2021
Figure 21: UK Ovarian Cancer Market Share by Products (%), 2016
Figure 22: UK Ovarian Cancer Market - Future Market Share (%), 2021
Figure 23: Europe Ovarian Cancer Market Size ($mn), 2012 - 2021
Figure 24: Europe Ovarian Cancer Product Sales ($mn), 2012 - 2021
Figure 25: Europe Ovarian Cancer Market Share by Products (%), 2016
Figure 26: Europe Ovarian Cancer Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report